Clin2
NCT06940193Likely a fitEnrolling by invitation

Egoo Phe home test for phenylalanine levels in PKU

Phenylketonuria (PKU)

Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.

This study tests a new home blood test (Egoo Phe) for measuring phenylalanine levels in people with PKU, as well as in healthy adults. It aims to see if it is accurate and easy to use.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
20 people
Ages
Up to 3 years
Study type
Observational

Who can take part

  • You must be 3 years or older.
  • You have a confirmed diagnosis of PKU (or you are a healthy adult over 18 without PKU).
  • You are comfortable with blood sampling and do not have a needle phobia.
  • You do not have any other medical conditions or chronic illnesses like diabetes that could affect the blood sampling.
  • You are not currently sick with an acute illness like chicken pox or a severe sore throat.
  • You are willing to participate and follow the study instructions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07671859Not yet recruiting
PKU Microtablets: A Study for People with PKU

This study tests a new microtablet form of protein substitute for people with PKU. It aims to see if taking these tablets helps you meet your protein needs while staying on your PKU diet.

Bristol
NCT07484945Recruiting
Multiomics study in adults with phenylketonuria

This study looks at adults with phenylketonuria (PKU) using advanced testing (called multiomics) to understand how the condition affects the body. If you took part in a previous PKU study (ECOPHEN) and are willing to give a saliva sample for DNA analysis, this trial may be for you.

Angers
NCT07672756Recruiting· Phase 1
Testing PL54 injection for adults with PKU

This study tests a new injection called PL54 to see if it is safe and tolerable for adults with phenylketonuria (PKU), a condition where the body cannot break down an amino acid called phenylalanine. It is designed for people with high blood phenylalanine levels and may offer a new treatment option.

Hefei, Anhui
NCT07318909Not yet recruiting· Early Phase 1
Testing GS1168 injection for adults with PKU

This study tests a new injection called GS1168 for adults with phenylketonuria (PKU) whose current treatments are not working well. The goal is to see if it can help control their PKU better.

Hefei, Anhui
NCT07406009Not yet recruiting
Psychosocial functioning in adults with PKU

This study looks at how adults with phenylketonuria (PKU) or hyperphenylalaninemia (HMP) are doing socially and emotionally. They will ask you and a relative who lives with you to answer questionnaires about daily life.

NCT06941532Recruiting
Study of GMP powder for PKU and tyrosinemia

This trial tests a new powdered protein substitute (GMP) for people with PKU or tyrosinemia. It aims to see if it is a safe and effective option to help manage their condition.

Birmingham

Hear when a new Phenylketonuria (PKU) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.